sglt2 inhibitors and glp 1 agonist 3. Integration of GLP-1RA or SGLT2i in Patients With T2D With or at Risk of atherosclerotic CVD Metabolic Powerhouses: GLP-1 RAs and

25 ChatterjeeS.NoackH.PosselH.WolfG

Back to Journals Clinical Interventions in Aging Volume 11 Efficacy of L-carnitine supplementation on frailty status and its biomarkers, nutritional status, and physical and cognitive function among prefrail older adults: a double-blind, randomized, placebo-controlled clinical trial Authors Badrasawi M , Shahar S, Zahara AM, Nor Fadilah R, Singh DKA Received 21 May 2016 Accepted for publication 17 June 2016 Published 17 November 2016 Volume 2016:11 Pages 16751686 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Richard Walker M Badrasawi, 1,2 Suzana Shahar, 1 AM Zahara, 1 R Nor Fadilah, 3 Devinder Kaur Ajit Singh 4 1 Dietetic Programme, School of Healthcare Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

L.Merkulova-RainonT.FaynboymA.ShestopalovV

More recently, medications have been developed that act on both the GLP1 receptor and the GIP receptor (so theyre dual agonists)

The remarkable beneficial effects of GSH on Helicobacter -induced inflammation and epithelial cell homeostasis suggest that GSH supplementation could be considered as a supportive therapy during and even after a Helicobacter eradication therapy

10.1155/2024/2247748 159 Samuelsen.HauklandH